Development, Safety, Issues, and Challenges of the SARS-CoV-2 Vaccine

Yasunari Matsuzaka; Ryu Yashiro

doi:10.3390/vaccines11030569

Vaccines (Mar 2023)

Development, Safety, Issues, and Challenges of the SARS-CoV-2 Vaccine

Yasunari Matsuzaka,
Ryu Yashiro

Affiliations

Yasunari Matsuzaka: Division of Molecular and Medical Genetics, Center for Gene and Cell Therapy, The Institute of Medical Science, University of Tokyo, Minato-ku 108-8639, Tokyo, Japan
Ryu Yashiro: Administrative Section of Radiation Protection, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Kodaira 187-8551, Tokyo, Japan

DOI: https://doi.org/10.3390/vaccines11030569
Journal volume & issue: Vol. 11, no. 3
p. 569

Abstract

Read online

It has been reported that some mutant strains of the new coronavirus escape from neutralizing antibodies acquired by recoverees and vaccine recipients, in which the Omicron strain (B [...]

n/a

Published in Vaccines

ISSN: 2076-393X (Online)
Publisher: MDPI AG
Country of publisher: Switzerland
LCC subjects: Medicine
Website: http://www.mdpi.com/journal/vaccines

About the journal

Abstract

Keywords